NCT02890069 2023-01-11A Study of PDR001 in Combination With LCL161, Everolimus or PanobinostatNovartisPhase 1 Completed298 enrolled
NCT00493766 2020-12-19Safety of LBH589 Alone and in Combination With IV Docetaxel and PrednisoneNovartisPhase 1 Terminated16 enrolled
NCT00503451 2020-12-19A Study to Investigate the Effects of Ketoconazole on LBH589 in Patients With Advanced Solid TumorsNovartisPhase 1 Completed14 enrolled
NCT00532675 2020-12-19Safety Study of LBH589 When Given in Combination With Lenalidomide and Dexamethasone in Adult Patients With Multiple Myeloma.NovartisPhase 1 Completed46 enrolled
NCT00570284 2020-12-19A Study to Investigate the Effect of Food on Oral LBH589 Absorption in Patients With Advanced Solid TumorsNovartisPhase 1 Completed36 enrolled
NCT00739414 2020-12-19Dose-escalating Study of LBH589 in Adult Patients With Advanced Solid TumorsNovartisPhase 1 Completed14 enrolled
NCT00788931 2020-12-19A Trial l of Panobinostat Given in Combination With Trastuzumab and Paclitaxel in Adult Female Patients With HER2 Positive Metastatic Breast CancerNovartisPhase 1 Completed15 enrolled
NCT00997399 2020-12-19Study to Evaluate Panobinostat (DACi) Pharmacokinetics and Safety in Solid Tumors and Varying Renal FunctionNovartisPhase 1 Completed37 enrolled
NCT01242774 2020-12-19Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)NovartisPhase 1 Completed46 enrolled
NCT01613976 2020-12-19A Phase Ib Study of Panobinostat (LBH589) in Combination With 5-Azacitidine for Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML) PatientsNovartisPhase 1 Completed10 enrolled
NCT00412997 2012-11-27LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell LymphomaNovartisPhase 1 Completed14 enrolled
NCT00472368 2012-05-01A Study to Determine the Absorption, Distribution, Metabolism, and Excretion of LBH589NovartisPhase 1 Completed4 enrolled
NCT00419536 2010-04-08Safety of LBH589 Alone and in Combination With Intravenous Docetaxel and PrednisoneNovartisPhase 1 Terminated108 enrolled